{"name":"Next Science TM","slug":"next-science-tm","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Next Science Acne Gel","genericName":"Next Science Acne Gel","slug":"next-science-acne-gel","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Next Science Acne Gel","genericName":"Next Science Acne Gel","slug":"next-science-acne-gel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxNSDFMOEM4YzNTRFI4czFBbUVIWm5NR0VzQ0NBQ3pJOTQtMkpmUnhvNGJwdkJtZ0R6bFVlb3pfZ2JOVnZIbVV5Wjh2bVdQQ3Y0eFBkV1lSNmxtZkJSUFduV3NaQXpqR2I4a0lnV0ZyNFBHVFlnV1luSXczNmFWa0l2bVVEYTJrUndNMGNIUjhDZlV0U0ZsLXpnUFE0NmhWRTlWaXZ4cGU0QTVlR2xQeFZyWWNxRGNSNU52V3B4R2dKZ084RWVJaFNBLVVhd0hVU1lzOXpxR29ZYnFsMXo3amJtQXVEdjFKeFhycS1RbmFDSEZOR3JWaGM1emZuZ1A3UnVZR3FLUXR3?oc=5","date":"2026-02-10","type":"trial","source":"globenewswire.com","summary":"Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution - globenewswire.com","headline":"Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQc05mR2U3YndCaUhxR1ZqVVpRenMzbklzcDdjVjJocGs3UEtFQ1lKU2lWTGNhQWJJbnVGWllJeFdVOUkxcExiZ05HRXhMckNzM0dvdk9WajdYLXZIT0ZTZ3B2YmdjX3dPamRYX3ZsVDA2VUQ0WHloaWkwTWZHSjRhX192enJMdXhMTTFXNjIxcEFOZmhTbFp2SG5tek5UeXhoOHNRcGNxbzZIZmc1RUhYQ1FtZ1FyNjg4dDVYajVlX2ExbEMwTnVIaA?oc=5","date":"2025-04-30","type":"pipeline","source":"World Health Organization (WHO)","summary":"Restoring balance: Traditional Medicine at the World Health Summit Regional Meeting 2025 - World Health Organization (WHO)","headline":"Restoring balance: Traditional Medicine at the World Health Summit Regional Meeting 2025 - World Health Organization (WH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQOVZncklGc0lCbS1JZjFJei04RWpERURReUpOdnRoS25BQ3NhSG9aZ3NCcklIbmVscnRMcFZkckV0VFN1c0NZb3c3dWROejFHZkowTVY5TWMyQ3huSU5zeUYtRDBnRTI3ZGJyMzkwVEpWcXpPbERZUzNFdjlvZXNESVBFSWNkYXRNMWhZbDJBbDRlT1NHN2RUOFFOc3pDbXI3MFhuVWRHeFdrMjBXNVNSUnNkaWR4Q04tdEhLMnluM09zNkRlQmNEMWNIOA?oc=5","date":"2024-12-11","type":"pipeline","source":"monash.edu","summary":"Australia’s first mRNA vaccine candidate addresses COVID ‘immune imprinting’ - monash.edu","headline":"Australia’s first mRNA vaccine candidate addresses COVID ‘immune imprinting’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNR0RkMnNEaTJhR1dIR0ptVFRzV3p4OTlrRloxbkFPd0dkdnp3OGpKRjVZVEhqeEdOczZnd0xDQUZZdXRQalNvaXh1OUxuWGktV2h5WWlCdmhjSXJ0SkVjR0wxXzhFUmZqUUhOYzR2MzZLNm9pT3hyNTdtTU1HbUREQmwxN3dyOXJjdHdsNFB6TGpCTlA3ZmRGVVhmRWRfZ256Z2VmbWM5Z1pRQVU5aEptd2ZsTzVPWG1Pd2Z6MXFMam1DbWlqSTd3Z0hfTG9KSmdNVXJpaVdJd2hmZk90Q1U5cFRDZ1RLWHZBd3c?oc=5","date":"2020-06-17","type":"pipeline","source":"Business Wire","summary":"Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines - Business Wire","headline":"Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}